ABCB1 (MDR1, P-Glycoprotein) C3435T Gene Polymorphism and its Possible Association with Chronic Myeloid Leukemia Prognosis

Order of Publishing in Issue: 
Volume :2
Issue :4
October, 2008
Page No: 
514 -522
K.Sailaja, D.Surekha, D.Nageswara Rao, D.Raghunadha Rao1, S.Vishnupriya*
Department of Genetics, Osmania University, Hyderabad, India
1Nizam’s Institute of Medical Sciences, Hyderabad, India

Adenosine triphosphate-binding cassette B1 (MDR1- multiple drug resistance gene1), a drugtransporter gene encodes a transmembrane - glycoprotein (P-gp), which functions as an effluxpump for various structurally unrelated anticancer agents and toxins. Our main objective is to studyMDR1 gene polymorphism at C3435T in chronic myeloid leukemia (CML) to understand itsassociation with development and response to drug (Imatinib) treatment. The present study comprises of 150 CML cases and 150 age and sex matched controls. MDR1 C3435Tpolymorphism was analyzed through polymerase chain reaction followed by restriction enzymedigestion (PCR-RFLP). The MDR1 genotype distribution revealed elevated frequency of TTgenotype in CML patients (34%) when compared to controls (28.67%). Within the disease group,T allele frequency (0.59) was elevated as compared to C allele frequency (0.41). Thefunctional significance of MDR1 C3435T polymorphism with respect to Imatinib (P-gpsubstrate) treatment was also studied in terms of hematological and cytogenetic responses.Patients without hematological response had higher frequency of TT genotype (52.63%) ascompared to those with major (32.23%) or minor (20%) hematological response. Whereas patientswithout cytogenetic response had higher frequency of CC genotype (27.03%) comparedto those with major (15.15%) or minor (10.64%) cytogenetic response When the data wascompared in relation to combination of both typesof responses, the frequency of CC genotype was increased significantly in cytogenetic nonrespondersand the increase was found to be inversely proportional to the degree of cytogenetic response. This could be attributed toover expression of P-gp in individuals with CC genotype that might have resulted in increasedefflux of Imatinib, a P-gp substrate leading to drug resistance. The present study indicates the possible association of MDR1 (C3435T) polymorphismwith increased risk for development of CML in T allele carriers

MDR1 gene, Chronic myeloid leukemia, Single nucleotide polymorphism, PCR-RFLP.
514-522[5].pdf95.43 KB

To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.



User login